Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Acute Radiation Syndrome

Abstract EN

With the extensive utilization of radioactive materials for medical, industrial, agricultural, military, and research purposes, medical researchers are trying to identify new methods to treat acute radiation syndrome (ARS).

Radiation may cause injury to different tissues and organs, but no single drug has been proven to be effective in all circumstances.

Radioprotective agents are always effective if given before irradiation, but many nuclear accidents are unpredictable.

Medical countermeasures that can be beneficial to different organ and tissue injuries caused by radiation are urgently needed.

Cellular therapy, especially stem cell therapy, has been a promising approach in ARS.

Hematopoietic stem cells (HSCs) and mesenchymal stromal cells (MSCs) are the two main kinds of stem cells which show good efficacy in ARS and have attracted great attention from researchers.

There are also some limitations that need to be investigated in future studies.

In recent years, there are also some novel methods of stem cells that could possibly be applied on ARS, like “drug” stem cell banks obtained from clinical grade human induced pluripotent stem cells (hiPSCs), MSC-derived products, and infusion of HSCs without preconditioning treatment, which make us confident in the future treatment of ARS.

This review focuses on major scientific and clinical advances of hematopoietic stem cells and mesenchymal stromal cells on ARS.